Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
128.1 EUR | +0.71% | -6.68% | +6.44% |
05-17 | Reply Introduces the Latest Release of MLFRAME Reply | CI |
04-22 | Laife Reply Develosd, in Collaboration with IEO (European Institute of Oncology), the Value Based Medicine, a Web Platform | CI |
Sales 2024 * | 2.28B 2.48B 194B | Sales 2025 * | 2.53B 2.75B 215B | Capitalization | 4.71B 5.13B 401B |
---|---|---|---|---|---|
Net income 2024 * | 211M 230M 17.97B | Net income 2025 * | 236M 257M 20.1B | EV / Sales 2024 * | 1.9 x |
Net cash position 2024 * | 397M 432M 33.83B | Net cash position 2025 * | 565M 615M 48.14B | EV / Sales 2025 * | 1.64 x |
P/E ratio 2024 * |
22.4
x | P/E ratio 2025 * |
19.6
x | Employees | - |
Yield 2024 * |
0.89% | Yield 2025 * |
1.01% | Free-Float | 59.89% |
1 week | -6.68% | ||
1 month | +3.25% | ||
3 months | -0.86% | ||
6 months | +18.77% | ||
Current year | +6.44% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Rizzante
CEO | Chief Executive Officer | 76 | 31/05/96 |
Tatiana Rizzante
CEO | Chief Executive Officer | 54 | 31/12/02 |
Director/Board Member | 67 | 31/12/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 31/12/10 | |
Tatiana Rizzante
CEO | Chief Executive Officer | 54 | 31/12/02 |
Mario Rizzante
CEO | Chief Executive Officer | 76 | 31/05/96 |
Date | Price | Change |
---|---|---|
03/06/24 | 128.1 | +0.71% |
31/05/24 | 127.2 | -4.50% |
30/05/24 | 133.2 | +0.30% |
29/05/24 | 132.8 | -3.56% |
28/05/24 | 137.7 | 0.00% |
Real-time BOERSE MUENCHEN, June 03, 2024 at 06:13 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.64% | 15.35B | |
-6.59% | 8.57B | |
+3.06% | 7.19B | |
-51.95% | 3.88B | |
+11.91% | 2.97B | |
-20.42% | 2.22B | |
-7.48% | 2.11B | |
-18.64% | 1.93B | |
-37.38% | 1.1B |
- Stock Market
- Equities
- REY Stock
- REJA Stock